

Demis Hassabis
Researcher · Founder
Now Founder and CEO, Isomorphic Labs; Chair, Google DeepMind; Chief Scientist, Alphabet
Latest on AI4S.fyiCommentary · Oct 26 · named in itCommentary: Citation graphs may underestimate neuroscience’s influence on AIAccount links back to deepmind.com · Avatar from their X account, taken 2026-09-28
Affiliations
Current
- Founder and CEO · Isomorphic Labs
- Chair · Google DeepMind
- Chief Scientist · Alphabet
Previous
- CEO · Google DeepMind
Current roles come from these dated records, not from the bio below. Each links the page it was read from.
Honours
- Nobel Prize in Chemistry, for protein structure prediction
Prizes and academy memberships, kept apart from roles. Each links the page it was read from.
About
Demis Hassabis founded Isomorphic Labs, which builds AI models for drug discovery on and beyond AlphaFold, and co-founded DeepMind. He shared the 2024 Nobel Prize in Chemistry with John Jumper for protein structure prediction.
Read on 2026-09-29; for current roles see Affiliations above. Read at: isomorphiclabs.com ↗ · nobelprize.org ↗
Selected work
- Highly accurate protein structure prediction with AlphaFold ↗
AlphaFold2, which predicts a protein's 3D structure from its amino-acid sequence.
Also on this record: Simon Kohl, Oriol Vinyals
Each byline was read on the paper itself. Only people on this record are named, not the full author list, and a shared byline does not say who did which part.
Founded
Isomorphic LabsDrug discovery · 2021 · 3 rounds on record · disclosed $2.7B · Round (unnamed) Amount not reportedBackground: Google DeepMind (co-founder and CEO) (as the company's own announcements put it)
Backed byThrive Capital
On the timeline
- 2026-10-08Isomorphic Labs is in early talks to raise money at a valuation of at least $40B, five months after its $2.1B Series B, Bloomberg reports
- 2026-09-16Google DeepMind launches the DeepMind Institute to study AGI's societal impact
- 2026-08-05Demis Hassabis moves from DeepMind CEO to Alphabet Chief Scientist
- 2026-05-12Isomorphic Labs raises $2.1B in a Series B led by Thrive Capital to move its AI-designed programmes toward the clinic
- 2024-10-09The Chemistry Nobel recognizes protein design and AlphaFold
- 2023-04-20Google merges Brain and DeepMind into Google DeepMind
- 2021-11-01Alphabet launches Isomorphic Labs
Named in commentary
Something wrong or missing on this page? Tell me and it will be fixed or removed. Contact →
